23andMe chief strikes back after FDA warning

23andMe chief strikes back after FDA warning

"We stand behind the data that we return to customers—but we recognize that the FDA needs to be convinced of the quality of our data as well," Wojcicki said in a blog post on the company's website Tuesday night. On Nov. 22 the FDA ordered 23andMe to 

3
Like
Save

Comments

Write a comment

*